Search

Your search keyword '"Arbeit, Robert D"' showing total 331 results
Start Over Author "Arbeit, Robert D"
331 results on '"Arbeit, Robert D"'

4. Data from Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma

Author

Andtbacka, Robert H.I., primary, Wang, Yan, primary, Pierce, Robert H., primary, Campbell, Jean S., primary, Yushak, Melinda, primary, Milhem, Mohammed, primary, Ross, Merrick, primary, Niland, Katie, primary, Arbeit, Robert D., primary, Parasuraman, Sudha, primary, Bickley, Kris, primary, Yeung, Cecilia CS, primary, Aicher, Lauri D., primary, Smythe, Kimberly S., primary, and Gan, Lu, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Figure 2 from Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma

Author

Andtbacka, Robert H.I., primary, Wang, Yan, primary, Pierce, Robert H., primary, Campbell, Jean S., primary, Yushak, Melinda, primary, Milhem, Mohammed, primary, Ross, Merrick, primary, Niland, Katie, primary, Arbeit, Robert D., primary, Parasuraman, Sudha, primary, Bickley, Kris, primary, Yeung, Cecilia CS, primary, Aicher, Lauri D., primary, Smythe, Kimberly S., primary, and Gan, Lu, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Table 2 from Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma

Author

Andtbacka, Robert H.I., primary, Wang, Yan, primary, Pierce, Robert H., primary, Campbell, Jean S., primary, Yushak, Melinda, primary, Milhem, Mohammed, primary, Ross, Merrick, primary, Niland, Katie, primary, Arbeit, Robert D., primary, Parasuraman, Sudha, primary, Bickley, Kris, primary, Yeung, Cecilia CS, primary, Aicher, Lauri D., primary, Smythe, Kimberly S., primary, and Gan, Lu, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Table 1 from Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma

Author

Andtbacka, Robert H.I., primary, Wang, Yan, primary, Pierce, Robert H., primary, Campbell, Jean S., primary, Yushak, Melinda, primary, Milhem, Mohammed, primary, Ross, Merrick, primary, Niland, Katie, primary, Arbeit, Robert D., primary, Parasuraman, Sudha, primary, Bickley, Kris, primary, Yeung, Cecilia CS, primary, Aicher, Lauri D., primary, Smythe, Kimberly S., primary, and Gan, Lu, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Figure 1 from Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma

Author

Andtbacka, Robert H.I., primary, Wang, Yan, primary, Pierce, Robert H., primary, Campbell, Jean S., primary, Yushak, Melinda, primary, Milhem, Mohammed, primary, Ross, Merrick, primary, Niland, Katie, primary, Arbeit, Robert D., primary, Parasuraman, Sudha, primary, Bickley, Kris, primary, Yeung, Cecilia CS, primary, Aicher, Lauri D., primary, Smythe, Kimberly S., primary, and Gan, Lu, primary

Published
2023
Full Text
View/download PDF

9. Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma

Author

Andtbacka, Robert H.I., primary, Wang, Yan, additional, Pierce, Robert H., additional, Campbell, Jean S., additional, Yushak, Melinda, additional, Milhem, Mohammed, additional, Ross, Merrick, additional, Niland, Katie, additional, Arbeit, Robert D., additional, Parasuraman, Sudha, additional, Bickley, Kris, additional, Yeung, Cecilia CS, additional, Aicher, Lauri D., additional, Smythe, Kimberly S., additional, and Gan, Lu, additional

Published
2022
Full Text
View/download PDF

12. Safety of Zoster Vaccine in Elderly Adults Following Documented Herpes Zoster

Author

Morrison, Vicki A., Oxman, Michael N., Levin, Myron J., Schmader, Kenneth E., Guatelli, John C., Betts, Robert F., Gelb, Larry D., Pachucki, Constance T., Keay, Susan K., Menzies, Barbara, Griffin, Marie R., Kauffman, Carol A., Marques, Adriana R., Toney, John F., Simberkoff, Michael S., Serrao, Richard, Arbeit, Robert D., Gnann, John W., Greenberg, Richard N., Holodniy, Mark, Keitel, Wendy A., Yeh, Shingshing S., Davis, Larry E., Crawford, George E., Neuzil, Kathy M., Johnson, Gary R., Zhang, Jane H., Harbecke, Rith, Chan, Ivan S. F., Keller, Paul M., Williams, Heather M., Boardman, Kathy D., Silber, Jeffrey L., and Annunziato, Paula W.

Published
2013
Full Text
View/download PDF

14. Varicella-Zoster Virus–Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine

Author

Weinberg, Adriana, Zhang, Jane H., Oxman, Michael N., Johnson, Gary R., Hayward, Anthony R., Caulfield, Michael J., Irwin, Michael R., Clair, James, Smith, Jeffrey G., Stanley, Harold, Marchese, Rocio D., Harbecke, Ruth, Williams, Heather M., Chan, Ivan S. F., Arbeit, Robert D., Gershon, Anne A., Schödel, Florian, Morrison, Vicki A., Kauffman, Carol A., Straus, Steve E., Schmader, Kenneth E., Davis, Larry E., and Levin, Myron J.

Published
2009

17. Persistent Bacteremia Due to Methidllin-Resistant Staphylococcus aureus Infection Is Associated with agr Dysfunction and Low-Level in Vitro Resistance to Thrombin-Induced Platelet Microbicidal Protein

Author

Fowler, Vance G., Sakoulas, George, Mclntyre, Lauren M., Meka, Venkata G., Arbeit, Robert D., Cabell, Christopher H., Stryjewski, Martin E., Eliopoulos, George M., Reller, L. Barth, Corey, G. Ralph, Jones, Tiffanny, Lucindo, Natalie, Yeaman, Michael R., and Bayer, Arnold S.

Published
2004

26. Campylobacteriosis, Eastern Townships, Quebec

Author

Michaud, Sophie, Menard, Suzanne, and Arbeit, Robert D.

Subjects
Campylobacter infections -- Risk factors, Campylobacter infections -- Research
Abstract

Independent risk factors for campylobacteriosis (eating raw, rare, or undercooked poultry; consuming raw milk or raw milk products; and eating chicken or turkey in a commercial establishment) account for ********** [...]

Published
2004

27. DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: A randomized controlled, double-blind phase 2b trial

Author

Munseri, Patricia, primary, Said, Jamila, additional, Amour, Maryam, additional, Magohe, Albert, additional, Matee, Mecky, additional, Rees, Christiaan A., additional, Mackenzie, Todd, additional, Tvaroha, Susan, additional, Bailey-Kellogg, Chris, additional, Maro, Isaac, additional, Wieland-Alter, Wendy, additional, Adams, Lisa V., additional, Horsburgh, C. Robert, additional, Nakamura, Keiko, additional, Arbeit, Robert D., additional, Pallangyo, Kisali, additional, and von Reyn, C. Fordham, additional

Published
2020
Full Text
View/download PDF

30. Safety of Herpes Zoster Vaccine in the Shingles Prevention Study: A Randomized Trial

Author

Simberkoff, Michael S., Arbeit, Robert D., Johnson, Gary R., Oxman, Michael N., Boardman, Kathy D., Williams, Heather M., Levin, Myron J., Schmader, Kenneth E., Gelb, Lawrence D., Keay, Susan, Neuzil, Kathleen, Greenberg, Richard N., Griffin, Marie R., Davis, Larry E., Morrison, Vicki A., and Annunziato, Paula W.

Published
2010

32. A Real-Time PCR Assay to Identify and Discriminate Among Wild-Type and Vaccine Strains of Varicella-Zoster Virus and Herpes Simplex Virus in Clinical Specimens, and Comparison With the Clinical Diagnoses

Author

Harbecke, Ruth, Oxman, Michael N., Arnold, Beth A., Ip, Charlotte, Johnson, Gary R., Levin, Myron J., Gelb, Lawrence D., Schmader, Kenneth E., Straus, Stephen E., Wang, Hui, Wright, Peter F., Pachucki, Constance T., Gershon, Anne A., Arbeit, Robert D., Davis, Larry E., Simberkoff, Michael S., Weinberg, Adriana, Williams, Heather M., Cheney, Carol, Petrukhin, Luba, Abraham, Katalin G., Shaw, Alan, Manoff, Susan, Antonello, Joseph M., Green, Tina, Wang, Yue, Tan, Charles, and Keller, Paul M.

Published
2009
Full Text
View/download PDF

41. The role of bacterial adhesins in the outcome of childhood urinary tract infections

Author

Johnson, Candice E., Maslow, Joel N., Fattlar, Deborah C., Adams, Kenneth S., and Arbeit, Robert D.

Subjects
Urinary tract infections in children -- Drug therapy, Antibiotics -- Dosage and administration, Bacteria -- Adhesion, Family and marriage, Health
Abstract

* Objective. - To compare the efficacy of 3-day vs 10-day treatment with a combination of amoxicillin and clavulanate potassium for children with uncomplicated urinary tract infections and to determine the role of host factors, including vesicoureteral reflux, and of bacterial virulence factors, including adhesins, in treatment outcome. Design. - Randomized, double-blind, controlled trial. Setting. - A pediatric infectious diseases clinic at an urban medical center. Patients. - Thirty-seven children with uncomplicated urinary tract infections. Interventions. - Treatment with 3 days or 10 days of antibiotics at a dosage of 20 mg/kg per day of amoxicillin and 5 mg/kg per day of clavulanate potassium in three divided doses. Measurements and Main Results. - The success rate for 10-day treatment was 82% (14/17) compared with 55% (11/20) for 3-day treatment (P=.09). Among the 35 patients infected with Escherichia coli, all 10 patients infected with adhesin-negative isolates were treated successfully regardless of the duration of treatment, whereas only 14 (56%) of the 25 infections involving adhesin-positive isolates were clinically cured (P=.015). Two of the three failures in the 10-day treatment group were in patients with reflux. Conclusions. - We conclude that 3-day treatment with amoxicillin and clavulanate is insufficient for afebrile childhood urinary tract infections and that both bacterial and host factors affect treatment outcome. (AJDC. 1993;147:1090-1093), Three-day treatment with amoxicillin and clavulanate potassium appeared to be insufficient compared with 10-day treatment in afebrile childhood urinary tract infections. Both bacterial factors, such as adhesins, and host factors, such as vesicoureteral reflux, were variables in the outcome of treatment. A randomized, double-blind, controlled trial was conducted among 37 children with uncomplicated urinary tract infections at a pediatric infectious diseases clinic in an urban medical center. The children were treated with a drug regimen of either 3 or 10 days of antibiotics at a dosage of 20 mg/kg per day of amoxicillin and 5 mg/kg per day of clavulanate potassium in three divided doses. The 10-day treatment had a success rate of 82%, compared with 55% for the 3-day treatment.

Published
1993

Catalog

Books, media, physical & digital resources
See catalog results